231 – 240 of 459
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
PSA quantification of 80 plasma samples from the clinical routine using antibody microarrays
2009) 13th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2009 In Proceedings of Conference, MicroTAS 2009 - The 13th International Conference on Miniaturized Systems for Chemistry and Life Sciences p.457-459(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Maldi-target integrated microfluidic PSA assay
2009) 13th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2009 In Proceedings of Conference, MicroTAS 2009 - The 13th International Conference on Miniaturized Systems for Chemistry and Life Sciences p.1064-1066(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2008
-
Mark
Beta-microseminoprotein in serum correlates with the levels in seminal plasma of young, healthy males
(
- Contribution to journal › Article
-
Mark
Long-term prediction of prostate cancer: Prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population
(
- Contribution to journal › Article
-
Mark
Total prostate specific antigen stability confirmed after long-term storage of serum at -80C - Comment
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
ENSAM: Europium Nanoparticles for Signal Enhancement of Antibody Microarrays on Nanoporous Silicon.
(
- Contribution to journal › Article
-
Mark
Alteration of prostate specific antigen (PSA) in blood linked to cancer
2008) Swedish Proteomics Society Symposium, 2008(
- Contribution to conference › Abstract
-
Mark
The role of SPINK1 in ETS rearrangement-negative prostate cancers
(
- Contribution to journal › Article
-
Mark
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring
(
- Contribution to journal › Scientific review
-
Mark
Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study
(
- Contribution to journal › Article